{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:56:41Z","timestamp":1787165801519,"version":"build-2736575974"},"reference-count":51,"publisher":"Edizioni Minerva Medica","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Q J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.23736\/s1824-4785.22.03468-9","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T10:03:42Z","timestamp":1666778622000},"source":"Crossref","is-referenced-by-count":1,"title":["A retrospective study with long term follow-up of Graves' disease patients treated with low activities of 131Iodine"],"prefix":"10.23736","volume":"68","author":[{"given":"Regina","family":"NEUMANN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"THOMANN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard W.","family":"GOERRES","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17149","reference":[{"key":"10.23736\/S1824-4785.22.03468-9_ref001","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0b013e3283432c5c"},{"key":"10.23736\/S1824-4785.22.03468-9_ref002","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000000840"},{"key":"10.23736\/S1824-4785.22.03468-9_ref003","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1995.tb02039.x"},{"key":"10.23736\/S1824-4785.22.03468-9_ref004","first-page":"213","article-title":"[Radioiodine therapy for benign thyroid diseases (version 5). German Guideline]","volume":"55","author":"Dietlein M","year":"2016","journal-title":"Nucl Med (Stuttg)"},{"key":"10.23736\/S1824-4785.22.03468-9_ref005","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020805"},{"key":"10.23736\/S1824-4785.22.03468-9_ref006","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0000000000000826"},{"key":"10.23736\/S1824-4785.22.03468-9_ref007","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2004.01349.x"},{"key":"10.23736\/S1824-4785.22.03468-9_ref008","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-010-1536-8"},{"key":"10.23736\/S1824-4785.22.03468-9_ref009","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0229"},{"key":"10.23736\/S1824-4785.22.03468-9_ref010","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-007-0618-8"},{"key":"10.23736\/S1824-4785.22.03468-9_ref011","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.17-5-453"},{"key":"10.23736\/S1824-4785.22.03468-9_ref012","doi-asserted-by":"publisher","DOI":"10.1186\/s40658-018-0231-x"},{"key":"10.23736\/S1824-4785.22.03468-9_ref013","doi-asserted-by":"publisher","DOI":"10.5603\/EP.2015.0019"},{"key":"10.23736\/S1824-4785.22.03468-9_ref014","doi-asserted-by":"publisher","DOI":"10.1007\/s002590100621"},{"key":"10.23736\/S1824-4785.22.03468-9_ref015","first-page":"241","article-title":"One-year follow-up of Graves' disease treatment by four different protocols of radioiodine administration","volume":"42","author":"Calegaro JU","year":"2000","journal-title":"Panminerva Med"},{"key":"10.23736\/S1824-4785.22.03468-9_ref016","first-page":"3611","article-title":"Radioiodine treatment of hyperthyroidism-prognostic factors for outcome","volume":"86","author":"Allahabadia A","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.23736\/S1824-4785.22.03468-9_ref017","first-page":"1229","article-title":"Success rate of radioiodine therapy in Graves' disease: the influence of thyrostatic medication","volume":"84","author":"Sabri O","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.23736\/S1824-4785.22.03468-9_ref018","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1625307"},{"key":"10.23736\/S1824-4785.22.03468-9_ref019","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.246017"},{"key":"10.23736\/S1824-4785.22.03468-9_ref020","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.139234"},{"key":"10.23736\/S1824-4785.22.03468-9_ref021","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.02152.x"},{"key":"10.23736\/S1824-4785.22.03468-9_ref022","doi-asserted-by":"publisher","DOI":"10.1007\/BF00173482"},{"key":"10.23736\/S1824-4785.22.03468-9_ref023","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1629688"},{"key":"10.23736\/S1824-4785.22.03468-9_ref024","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2005.20.218"},{"key":"10.23736\/S1824-4785.22.03468-9_ref025","doi-asserted-by":"publisher","DOI":"10.14712\/18059694.2014.39"},{"key":"10.23736\/S1824-4785.22.03468-9_ref026","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-018-0322-7"},{"key":"10.23736\/S1824-4785.22.03468-9_ref027","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1995.tb01230.x"},{"key":"10.23736\/S1824-4785.22.03468-9_ref028","first-page":"e139","article-title":"131I therapy and Graves' disease in a long term observation: euthyroidism is a suitable goal. Our experience","volume":"165","author":"Montesano T","year":"2014","journal-title":"Clin Ter"},{"key":"10.23736\/S1824-4785.22.03468-9_ref029","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-017-1253-1"},{"key":"10.23736\/S1824-4785.22.03468-9_ref030","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1410117"},{"key":"10.23736\/S1824-4785.22.03468-9_ref031","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.139222"},{"key":"10.23736\/S1824-4785.22.03468-9_ref032","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2016.31.1.168"},{"key":"10.23736\/S1824-4785.22.03468-9_ref033","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2385-1-1"},{"key":"10.23736\/S1824-4785.22.03468-9_ref034","first-page":"158","article-title":"Comparative evaluation of two fixed doses of 185 and 370 MBq 131I, for the treatment of Graves' disease resistant to antithyroid drugs","volume":"8","author":"Esfahani AF","year":"2005","journal-title":"Hell J Nucl Med"},{"key":"10.23736\/S1824-4785.22.03468-9_ref035","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-09-0286"},{"key":"10.23736\/S1824-4785.22.03468-9_ref036","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1999.9.865"},{"key":"10.23736\/S1824-4785.22.03468-9_ref037","first-page":"1038","article-title":"Age and gender predict the outcome of treatment for Graves' hyperthyroidism","volume":"85","author":"Allahabadia A","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.23736\/S1824-4785.22.03468-9_ref038","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20191609"},{"key":"10.23736\/S1824-4785.22.03468-9_ref039","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-002-0877-3"},{"key":"10.23736\/S1824-4785.22.03468-9_ref040","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-020-00557-w"},{"key":"10.23736\/S1824-4785.22.03468-9_ref041","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0000000000000285"},{"key":"10.23736\/S1824-4785.22.03468-9_ref042","doi-asserted-by":"publisher","DOI":"10.1186\/s40842-018-0071-6"},{"key":"10.23736\/S1824-4785.22.03468-9_ref043","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmp.2016.05.059"},{"key":"10.23736\/S1824-4785.22.03468-9_ref044","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0b013e3182817c78"},{"key":"10.23736\/S1824-4785.22.03468-9_ref045","doi-asserted-by":"publisher","DOI":"10.1210\/er.2012-1030"},{"key":"10.23736\/S1824-4785.22.03468-9_ref046","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0000000000000770"},{"key":"10.23736\/S1824-4785.22.03468-9_ref047","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.51.127"},{"key":"10.23736\/S1824-4785.22.03468-9_ref048","first-page":"1073","article-title":"High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease","volume":"87","author":"Alexander EK","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"#cr-split#-10.23736\/S1824-4785.22.03468-9_ref049.1","unstructured":"Wegleitung Radionuklidtherapie V1. 1 05.02.2021 (2021). Eidgen\u00f6ssisches Departement des Innern EDI, Bundesamt f\u00fcr Gesundheit BA. Wegleitungen f\u00fcr R\u00f6ntgenanlagen und radioaktive Stoffe. BAG"},{"key":"#cr-split#-10.23736\/S1824-4785.22.03468-9_ref049.2","unstructured":"2021 [Internet]. Available from: https:\/\/www.bag.admin.ch\/bag\/de\/home\/gesetze-und-bewilligungen\/gesuche-bewilligungen\/bewilligungen-aufsicht-im-strahlenschutz\/wegleitungen.html [cited 2022, Oct 19]."},{"key":"10.23736\/S1824-4785.22.03468-9_ref050","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-019-04580-5"}],"container-title":["The Quarterly Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"link":[{"URL":"https:\/\/www.minervamedica.it\/pdf.php?cod=R39Y2024N02A0116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T03:48:22Z","timestamp":1718077702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.minervamedica.it\/index2.php?show=R39Y2024N02A0116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":51,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.23736\/s1824-4785.22.03468-9","relation":{},"ISSN":["1824-4785","1827-1936"],"issn-type":[{"value":"1824-4785","type":"print"},{"value":"1827-1936","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6]]}}}